Citation Impact
Citing Papers
The 2017 hormone therapy position statement of The North American Menopause Society
2017
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Prevalence and risk of violence against children with disabilities: a systematic review and meta-analysis of observational studies
2012 Standout
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
2017
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Osteoporosis
2019 Standout
PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts
2013
Estrogen receptors and human disease
2006 Standout
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
2011 Standout
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
2018 Standout
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
2020
Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies
2017
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews
2010
Prevention of VTE in Nonsurgical Patients
2012 Standout
Long term hormone therapy for perimenopausal and postmenopausal women
2005
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
User testing and stakeholder feedback contributed to the development of understandable and useful Summary of Findings tables for Cochrane reviews
2010
Non-alcoholic fatty liver disease
2021 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
2011 Standout
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
2017 Standout
Prevention of Venous Thromboembolism
2004 Standout
Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis
2012
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity
2012
Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol
2016
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
ROBIS: A new tool to assess risk of bias in systematic reviews was developed
2015
Osteoarthritis
2019 Standout
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
2011 Standout
Literature review as a research methodology: An overview and guidelines
2019 Standout
Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010
2017
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery
2013
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Intra-articular corticosteroid for knee osteoarthritis
2015
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Cannabinoids for Medical Use
2015 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
2010 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Systematic Reviews of Diagnostic Test Accuracy
2008
Works of Anne Eisinga being referenced
Hormone therapy for preventing cardiovascular disease in post-menopausal women
2015
Enhancing access to reports of randomized trials published world-wide – the contribution of EMBASE records to the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library
2008
Developing a geographic search filter to identify randomised controlled trials in Africa: finding the optimal balance between sensitivity and precision
2011
Compression stockings for preventing deep vein thrombosis in airline passengers
2016
Better reporting of randomized trials in biomedical journal and conference abstracts
2007
Compression stockings to prevent deep vein thrombosis in long-haul airline passengers.
2006
Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE
2013